L. Qian

Overcoming acquired resistance to third-generation EGFR inhibitors by targeting activation of intrinsic apoptotic pathway through Mcl-1 inhibition, Bax activation, or both

T. Owonikoko, S. Ramalingam, Shi-Yong Sun, 2022, Oncogene.

Homologous recombination deficiency (HRD) can predict the therapeutic outcomes of immuno-neoadjuvant therapy in NSCLC patients

Yu-Chung Yang, C. Wang, Z. Yu, 2022, Journal of Hematology & Oncology.

Representativeness of Patients Enrolled in the Lung Cancer Master Protocol (Lung-MAP).

J. Gray, E. Sigal, M. Redman, 2023, JCO Precision Oncology.

Homologous recombination deficiency (HRD) can predict the therapeutic outcomes of immuno-neoadjuvant therapy in NSCLC patients

Yu-Chung Yang, C. Wang, Z. Yu, 2022, Journal of Hematology & Oncology.